MDSCs are important osteoclast precursors primed by B cells in rheumatoid arthritis
Authors:
- 24 June 2024
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 54 (9) , e2350823
Abstract
Osteoclast‐mediated bone erosion and deformation represent significant pathological features in rheumatoid arthritis (RA). Myeloid‐derived suppressor cells (MDSCs) and B cells have emerged as key contributors to the progression of RA. Nevertheless, their involvement, especially the interaction in RA osteoclastogenesis remains elusive. In this study, our results revealed a marked expansion of MDSCs in RA patients, and importantly, their abundance was positively correlated with radiographic damage evaluated by the Sharp/van der Heijde score. Notably, MDSCs derived from both RA patients and arthritic mice exhibited a heightened propensity to differentiate into osteoclasts compared with those from healthy individuals. Intriguingly, we observed that B cells from RA patients could augment the osteoclastogenic potential of MDSCs, which was also observed in arthritic mice. The impact of B cells on MDSC‐mediated osteoclastogenesis was found to be most pronounced in switched memory B cells, followed by CD21low B cells and naïve B cells. MDSCs from B‐cell‐deficient mice exhibited diminished capacity to differentiate into osteoclasts, accompanied by distinct gene expression profiles associated with osteoclastogenesis. Taken together, our findings suggested that MDSCs were important osteoclast precursors primed by B cells in RA, serving as novel therapeutic targets for the persistent disease.Keywords
Funding Information
- National Natural Science Foundation of China (82371807, 82171773, 81971523, 81671604, 82001718, U1903210, 32141004, 81871281)
- Beijing Nova Program (Z181100006218044, Z211100002121163)
- Beijing Science and Technology Planning Project (Z191100006619109, Z191100006619111)
This publication has 40 references indexed in Scilit:
- Novel Insights into Osteoclast Energy MetabolismCurrent Osteoporosis Reports, 2023
- IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapyCellular Immunology, 2021
- Anti‐interleukin‐6 signalling therapy rebalances the disrupted cytokine production of B cells from patients with active rheumatoid arthritisEuropean Journal of Immunology, 2017
- Periarticular Bone Loss in Arthritis Is Induced by Autoantibodies Against Citrullinated VimentinJournal of Bone and Mineral Research, 2017
- Myeloid-derived suppressor cells contribute to bone erosion in collagen-induced arthritis by differentiating to osteoclastsJournal of Autoimmunity, 2015
- Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid ArthritisArthritis & Rheumatology, 2015
- Myeloid-derived suppressor cells are proinflammatory and regulate collagen-induced arthritis through manipulating Th17 cell differentiationClinical Immunology, 2015
- B cells expressing IFN‐γ suppress Treg‐cell differentiation and promote autoimmune experimental arthritisEuropean Journal of Immunology, 2015
- Regulatory B10 Cells Are Decreased in Patients With Rheumatoid Arthritis and Are Inversely Correlated With Disease ActivityArthritis & Rheumatology, 2014
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986